Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Clinical trial NCT01508936 · COMPLETED
Trial details
- NCT number
- NCT01508936
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2013-08-01
- Enrollment
- 511
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.